Phio Pharmaceuticals Corp. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Phio Pharmaceuticals Corp. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2012 to 2023.
  • Phio Pharmaceuticals Corp. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$4M, a 10426% decline year-over-year.
  • Phio Pharmaceuticals Corp. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $7.41M.
  • Phio Pharmaceuticals Corp. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$26K, a 100% decline from 2021.
  • Phio Pharmaceuticals Corp. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $21.7M, a 34.7% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.